Last reviewed · How we verify

NCT06102382

The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section

Recruiting now NA Last updated 29 August 2025
What this trial tests

NA trial testing Norepinephrine (0.1) in Cesarean Section in 100 participants. Currently enrolling.

Timeline
1 September 2024
Primary endpoint
1 October 2025
1 December 2025

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment100
Start date1 September 2024
Primary completion1 October 2025
Estimated completion1 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 19 to 40, female only, with Cesarean Section or Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06102382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing